MAXCYTE, INC. 8-K

What Happened
On March 24, 2026, MaxCyte, Inc. announced its financial results for the quarter and year ended December 31, 2025 via a press release furnished as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02). The company also posted an updated corporate presentation to its investor website (Exhibit 99.2) under Regulation FD (Item 7.01). The filing notes these materials are furnished (not “filed”) and thus are not subject to Section 18 liability or automatically incorporated by reference in other SEC filings.

Key Details

• Filing date: March 24, 2026; reporting period: quarter and year ended December 31, 2025.
• Exhibit 99.1: Press release with the announced results; Exhibit 99.2: Updated corporate presentation posted at https://investors.maxcyte.com.
• The Form 8-K covers Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• The cover page interactive XBRL is included as Exhibit 104; the report was signed by CFO Douglas Swirsky.

Why It Matters
Retail investors should review the press release and the updated presentation to see the company’s reported earnings, revenue trends, and any management commentary for Q4 and full-year 2025. The Regulation FD disclosure indicates MaxCyte refreshed its investor materials, which can provide updated guidance, financial metrics, or strategic context—important inputs when evaluating the stock. This 8-K does not disclose management changes or transactions beyond the furnished results and presentation.